chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received her first dose on 3-12-21.  She received a call later that week from the clinic she got the vaccine at, and she was informed that the temperature was not right and that she received a batch that was bad.  She was asked to return to have the first dose repeated on 3-19-21.  After she got the dose on 3-19-21 she had terrible symptoms and side effects including but not limited to extreme fatigue, whole body pain, rash, chest pain, shortness of breath.  In the months to follow, she continued to have all of these symptoms and started to rapidly gain weight as well.  Her chest pain and shortness of breath got so severe that she was referred to a cardiologist and had a full work up including troponin, ECHO, coronary calcium score and ECG.  All of which were within in normal limits. She went to see her old PCP on 2 occasions and had a full panel of labs drawn each time, all of which returned normal.  When she came to see me, she still was experiencing shortness of breath, neck pressure and chest pressure. CXR and CT of her chest were done and were normal. Another full panel of labs were done and normal.  Also in the time frame after her covid vaccine on 3-19-21, she started breaking out in rashes intermittently. She needed to follow up with the dermatologist, who was unable to help her resolve the rash. It would wax and wane on its own.  Since that dose of covid vaccine March 19th, she has not been the same.  All of her symptoms started after that injection.  There is not other triggering event.  She still suffers from chronic fatigue, weight gain, chest pain, shortness of breath and breaks out in rashes.  Multiple specialists as well as primary care are still yet to determine the cause of her symptoms. The only precipitating event was that dose of the vaccine.
Starting late  2/4 Body Ache, Tightness in Chest. Body Ache went away 2/6, tightness in chest improved. 2/1o Tightness in Chest came back. Went to Dr. Was given steroid shot, zpac, and breathing treatments. EKG was done. Returned to Dr, 2/12. Breathing better. Another EKG was done, little change. Went to Cadiologist on 2/15. Will have nuclear stress test on 2/18. Cardiologist feels that this is not heart or lung related based on consultation, thinks that it is Covid related.
Tachycardia, tachypnea, low grade fever, nausea, vomiting. 4-5 hour course IV fluids. ZOFRAN, SOLUMEDROL, BENADRYL. ER monitoring EKG, ATIVAN.
This spontaneous report has been received from a physician and refers to a 15-month-old patient of an unknown gender. The patient's relevant medical history, concurrent conditions, and concomitant therapies were not reported. On 02-MAR-2017, the patient was vaccinated with the first dose of VARIVAX, intramuscularly (strength, dose, frequency, lot number, and expiration date were not reported) for prophylaxis. Subsequently, on 23-MAY-2017, the patient received the second dose of VARIVAX intramuscularly (strength, dose, and frequency were not reported; lot number L038130 with and expiration date 29-SEP-2017) for prophylaxis that was reconstituted with a properly stored sterile diluent (DILUENT MRK), and which was inadvertently administered early. The patient had no side effects reported. Additional information has been requested.
Headaches, tired, requiring excessive sleep of over 10 hours, normal sleep ranges from 6 to 7. Reported to clinic by wednesday, by Saturday was dealing with muscle weakness, at times between sleep and alertness, almost felt like I was paralyzed. Could not lift arms, make fist, and could only roll over to adjust discomfort, then the tiredness part set it, over 12 hours of sleeping, tiredness and lathargy.  Was fine for about five days, then symptons reappeared yesterday.
This case was reported by a consumer (also the subject) and described the occurrence of nausea in a female subject of unspecified age who was vaccinated with TETANUS vaccine (manufacturer unspecified). a physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of TETANUS vaccine (details unknown). At an unspecified time after vaccination with TETANUS vaccine, the subject experienced nausea, arms redness, swelling arm, pain and headache. At the time of reporting the events were unresolved. No further information was provided.
Patient had the FLUZONE vaccine on 10/4/17. She came to report a reaction on 10/5/17. States her arm is sore and very itchy. The area is blanched in color and firm to touch.  Area measures 1.5 inches long and 1 inch wide.
After vaccination everything seemd okay. I had sever arm pain for 2 days that I have to keep my arm in sling after the first dose. Second dose of covid vaccine caused just fever and malaise for a day and severe headache plus a little arm pain. My blood pressure started rising after a few weeks (3 or 4 weeks after). I had a visit with my pcp because of severe muscle cramp on right side neck in February, 2021 and somewhere in March or April, 2021 had an office visit. My BP was high (in previous visits with other PCP my BP is always normal. I use to work as research coordinator so to check the machine I would check my BP and it was on lower side just 6 months before this incidence). My PCP casually asked me to follow my BP. I started checking and my BP was in range of 140-150 systtolic/100-110 diastolic. On next visit in May or June 2021 she started me on lisinopril 10 mg OD. Meanwhile on a routine mammogram I was diagnosed with suspicion of cancer and was advised biopsy. I had my biopsy in September, 2021 and that came out normal. This incident was also suspected to be due to covid vaccine as I took both injections on left arm and had biopsy of same breast with suspicious mammogram.  I stopped lisinopril in December, 2021 as my BP was 100/50 to 100/40 with lisinopril. I kept a track and my BP was low consistently without Lisinopril. My employer implemented booster mandate and I have to take booster on 1/8/2022. My BP started rising up again and I am back on Lisinopril. My BP is not even controlled with Lisinopril. It's again in range of 140-150/105-110.  My health is deteriorated after covid vaccination and I regret my decision of taking this vaccine.
pain around the injection site; A spontaneous report was received from a consumer concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain around the injection site.  The patient's medical history included that he had mild case of COVID injection in October to November 2020, he also has a current condition of arthritis. Concomitant medications reported were Tylenol for drug use for unknown indication.  On 16 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Detail Batch Number) intramuscularly for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient experienced pain around the injection site (injection site pain).  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event was unknown.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On 19-SEP-2012, the patient received a dose of (Merck) VARIVAX subcutaneously (lot # not reported) in error. No concomitant medications were reported. No adverse effects was reported. Additional information has been requested.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium.
arm aches hurts to use; fever; body aches; Chills; headache; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd April 2019, the patient received the 2nd dose of Shingrix. In April 2019, less than a day after receiving Shingrix, the patient experienced pain in arm, fever, general body pain, chills and headache. On an unknown date, the outcome of the pain in arm, fever, general body pain, chills and headache were unknown.   It was unknown if the reporter considered the pain in arm, fever, general body pain, chills and headache to be related to Shingrix.  Additional details were provided as follows: The patient experienced arm aches which hurts to use , fever, body aches , chills and headache. The patient has been given permission for follow up.
My left arm had giant red welts appear first and then a few hours later more welts appeared on my right arm.  The are very red and very itchy. I have taken Benadryl and I am using cortisone ointment to help w the itchiness.
Face has stayed slightly red/broken out/more sensitive; Face has stayed slightly red/broken out/more sensitive; Next morning felt supercharged; Face has stayed slightly red/broken out/more sensitive; Headache; Nausea; Heart rate increased (fluttering); Face flushed bright red; Room spinning; Heart rate increased; Feeling odd; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (Heart rate increased (fluttering)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Patient is not sure, but thinks actually had COVID earlier in the outbreak.).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Mar-2021, the patient experienced CARDIAC FLUTTER (Heart rate increased (fluttering)) (seriousness criterion medically significant), FLUSHING (Face flushed bright red), VERTIGO (Room spinning), HEART RATE INCREASED (Heart rate increased), FEELING ABNORMAL (Feeling odd), HEADACHE (Headache) and NAUSEA (Nausea). On 02-Mar-2021, the patient experienced ERYTHEMA (Face has stayed slightly red/broken out/more sensitive), SENSITIVE SKIN (Face has stayed slightly red/broken out/more sensitive), ENERGY INCREASED (Next morning felt supercharged) and RASH (Face has stayed slightly red/broken out/more sensitive). At the time of the report, CARDIAC FLUTTER (Heart rate increased (fluttering)), FLUSHING (Face flushed bright red), VERTIGO (Room spinning), HEART RATE INCREASED (Heart rate increased), FEELING ABNORMAL (Feeling odd), ERYTHEMA (Face has stayed slightly red/broken out/more sensitive), SENSITIVE SKIN (Face has stayed slightly red/broken out/more sensitive), ENERGY INCREASED (Next morning felt supercharged), RASH (Face has stayed slightly red/broken out/more sensitive), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.; Sender's Comments: This case concerns a 5-year-old female with serious unexpected events of cardiac flutter, and nonserious unexpected heart rate increased, vertigo, rash, sensitive skin, erythema, flushing, feeling abnormal, energy increased, and expected headache and nausea.  Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt was given 2nd Havrix too soon, no harm to patient. Will need to be repeated
mom states pt had t105.4, very limp p/high pitched scream lasted several hrs; taken to ER where had difficulty lowering temp & MD said was about to have sz; stayed in ER several hrs until stable;
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter. No Concomitant medicines were reported.   This case was linked to MOD-2021-395985 (Patient Link).
nausea; fatigue; chills; hot; left arm sore; This is a spontaneous report from a non-contactable consumer (patient) received via COVAES portal. A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 04Feb2021 (Batch/Lot Number: EL3247) (at the age of 47-years-old) as dose 2, single for COVID-19 immunisation. Medical history included known allergies for latex. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number: EL3248) (at the age of 47-years-old) administered in left arm on 15Jan2021 for COVID-19 immunisation and experienced left arm soreness and fatigue. The patient experienced nausea, fatigue, chills, hot, left arm sore on 05Feb2021. The patient received treatment for the events. The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (Feeling sick), INJECTION SITE NODULE (Nodule injection site), FEELING COLD (Coldness general), VACCINATION SITE PAIN (Vaccination site pain) and INJECTION SITE PAIN (Injection site pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.  On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 29-Apr-2021, the patient experienced MALAISE (Feeling sick). On an unknown date, the patient experienced INJECTION SITE NODULE (Nodule injection site), FEELING COLD (Coldness general) and INJECTION SITE PAIN (Injection site pain). The patient was treated with ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa, at a dose of prefilled syringe and IBUPROFEN for Pain NOS, at an unspecified dose and frequency. At the time of the report, MALAISE (Feeling sick), FEELING COLD (Coldness general), VACCINATION SITE PAIN (Vaccination site pain) and INJECTION SITE PAIN (Injection site pain) outcome was unknown and INJECTION SITE NODULE (Nodule injection site) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. A solicited report from the USA by a consumer. Reporter did not allow further contact.
Was to receive SARS-2-COVID booster dose of 0.25ml instead received 0.50ml dose.
About an hour after my son received his vaccinations at his well child check he started becoming lethargic, his skin looked a grey color, the injection site was hot and he wouldn't let you touch it. He also screamed off and on for hours for 24 hours after his vaccinations...we tried spacing the vaccinations out on his next appointment which was 05/13/14 which the doctor suggested to see if he just couldn't handle that many at once or which ones were giving him a reaction and he still had the same reaction again for the second time on 05/13/14.
This spontaneous report as received from a healthcare worker refers to a 47 year old female patient who on 22-SEP-2014 was vaccinated with an expired dose of M-M-R II (lot # H016132, expiration date: 31-AUG-2014) (dose and route not reported). No adverse effects were reported. Additional information has been requested.
W/in 1/2 hr of vax pt developed difficulty in breathing & generalized hives; Hospitalized & treated w/Epi & DPH other meds; Recovered in 2-3hrs;
Pt admitted on 1/6 due to femur fracture.  Tested for COVID on 1/12 for SNF placement and positive.
RIGHT ARM (PNEUMOVAX ADMINISTERED) IS SWOLLEN. VERY PAINFUL TO TOUCH. NAUSEA AND VOMITING.
Swelling and drainage of right upper arm noted on 10/6/16 in afternoon. He was seen at ED and told to provide supportive care. Still getting worse on 10/7 so seen in clinic by Dr and found to have swelling of right upper arm with erythema and warmth and wound in center. Diagnosed with cellulitis and started treatment with clindamycin.
Right side chest pain and shoulder pain, shortness of breath and rapid heart rate. These effects seem to happen randomly and with varying degrees or intensity. Started experiencing effects 6/21 in the evening. Went to urgent care 6/24. Diagnosed at this time with heart murmur and tachyarrhythmia. Seeking referral to cardiologist.
Pt. rec flu shot, then got out of car & in back seat to hold her child. Immediately after son rec. his vaccine, pt. passed out. Several nurses moved her to the ground - used ammonia inhalant, had slight seizure activity. Unable to hear BP on other arm. EMS arrived quickly & taken to ER.
This spontaneous report was received from an office manager and refers to a 1 year-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 20-OCT-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475 :US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515::US-009507513-1704USA004516: US-009507513-1704USA004517:
Information has been received from a licensed professional nurse LPN concerning a 55 year old female who on Nov 14 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). Within 3 hours of the vaccination, on Nov 14 2005, the patient experienced an injection site reaction characterized by redness, swelling and warmth. Unspecified medical attention was sought. It was reported that the patients entire upper arm was affected and made it very difficult to raise her arm. The patient was treated with azithromycin Z Pak, diphenhydramine hydrochloride (Benadryl, steroids and cold compresses. At the time of this report the patients present status was unknown. No further information was provided. No product quality complaint was involved. The reporter considered the adverse events to be disabling. The reporter also considered the adverse events to be other important medical events (OMIC). Additional information has been requested.
Severe disorientation,  confusion unable to know how to drive home.  Unstable fear of falling ,  severe weakness.
A report received from a pharmacist concerning a 15 year old, male patient. Patient has received the Flu shot vaccination in the past (not FLUMIST). Patient had received nasal FLUMIST, (intranasal) started on an unknown date. On Saturday, Nov 14, 2015, patient was administered by a pharmacist FLUMIST quadrivalent. Thirty seconds after the second half of the vaccine was administered into the second nostril, the patient experience a drop coming out of his nostril onto his pants and then some more dripping occurred onto his lips area which the pharmacist wiped with a tissue. Action taken of FLUMIST was unknown. The outcome of inappropriate administration was unknown. The report was considered to be non-serious by reporter.
Approximately 2 weeks after vaccine I experienced numbness in extremities, severe pain, loss of vision. I was diagnosed with GBS at 3 weeks after vaccine. I received IVIG.
Complaints of dizziness and fullness to sinuses/head following vaccination, monitored for 35 minutes, no other symptoms, vital signs within normal limits.  Felt fine enough to leave. Provided vsafe.cdc.gov link and advised to call Work Health with any questions or present to ED with any worsening symptoms.
Fevers, chills, vomiting, dizziness, headache, Extreme tiredness. Severe weakness
Patient in coma, respiratory failure 2/2 intracerebral hemorrhage, intraventricular hemorrhage, and subarachnoid hemorrhage.
Information has been received from a health professional, concerning a 17 year old female patient who on 15-AUG-2008 was vaccinated with 0.5 mL dose of GARDISIL IM. On 15-AUG-2008, the patient "passed out as she was walking out of the room". On the same date, the patient recovered. Glucose test was performed and the result was not provided. The patient did seek medical attention. There was no product quality complaint. Additional information is expected.
Breakthrough case admission after 3 vaccines Moderna 5/18/21 lot# 023C21A;  Moderna 6/15/21 lo# 050C21A; Moderna 1/12/22 lot# 033H21A